Clinical Trials Logo

Clinical Trial Summary

Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.


Clinical Trial Description

Our hypothesis is that genes and their mutation are causative of certain types of polycythemia and thrombocytosis. These will be sought for by genetic and cell biology means. The purpose of the study is to identify the molecular defect of these disorders. 5-7 teaspoons of peripheral blood will be drawn on all study subjects. After DNA is obtained, linkage analysis and/or mutation analysis will be performed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00722527
Study type Observational
Source University of Utah
Contact Josef T Prchal, MD
Phone 801-581-4220
Email josef.prchal@hsc.utah.edu
Status Recruiting
Phase
Start date July 2006
Completion date July 2028

See also
  Status Clinical Trial Phase
Completed NCT02308787 - Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions N/A
Completed NCT01787552 - A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF Phase 1/Phase 2
Completed NCT02125318 - A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders Phase 2
Completed NCT00509899 - Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis Phase 1/Phase 2
Terminated NCT00882414 - Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD) Phase 2
Recruiting NCT03531515 - Predictors of Reactive Thrombocytosis in Critically Ill Septic Patients
Completed NCT01194349 - The Role of Reactive Thrombocytosis in Children With Pneumococcal Infection N/A